Updates in Autoimmune Diseases

According to the National Institutes of Health (NIH), approximately 23.5 million (7.2%) Americans have an autoimmune disease. However, the American Autoimmune Related Diseases Association (AARDA) estimates that 50 million Americans suffer from an autoimmune disease. This discrepancy may be due to the NIH statistics only including 24 diseases for which epidemiology studies are available. The estimated annual direct health care costs for autoimmune diseases are $100 billion which is 40% higher than direct costs associated with cancers. According to AARDA, the Department of Health and Human Services’ Office of Women’s Health states that autoimmune diseases are the most requested health topic by callers to the organization’s information center. Given the impact of autoimmune diseases on the US healthcare system, the goal of the this online program is to provide updates around diagnosis, new and emerging treatments and disease management for common autoimmune diseases.

The March 11, 2021 Madison Clinical Conference was recorded and is now available as an online program. If you attended the March 11 conference, you are not eligible to receive CE for this online version.

Developed & Conducted by the Division of Pharmacy Professional Development, School of Pharmacy, University of Wisconsin-Madison.

Overview

Course Objectives

At the end of the course, participants will be able to:

Describe basic immunology principles and apply them to common autoimmune diseases
Identify the similarities and differences between originator biologics and biosimilars and understand the process for biosimilar development and approval
Identify the symptoms of major autoimmune diseases and the complexities involved in diagnosing specific autoimmune diseases
Recognize new and emerging therapies for autoimmune diseases, their benefits and potential limitations
Recognize common adverse events associated with autoimmune disease therapies and be able to apply remediation strategies
Develop patient specific goals for managing autoimmune diseases

Who Should Attend

All pharmacists and nurses regardless of their practice setting who have a desire to enhance their knowledge regarding autoimmune diseases and related conditions.

Outline

Course Outline

Lecture 1	An Immunology Primer Speaker: Mary S. Hayney, PharmD, MPH, FCCP, BCPS Professor, Pharmacy Practice Division, UW-Madison School of Pharmacy
Lecture 2	Overview of Biologics and Biosimilars-Characteristics, Nomenclature and Process Speaker: Leslie Dickmann, PhD, MPH, Program Director, Division of Pharmacy Professional Development, UW-Madison School of Pharmacy
Lecture 3	Multiple Sclerosis Speaker: Natalie Schmitz, PharmD, PhD, Assistant Professor, Pharmacy Practice Division, UW-Madison, School of Pharmacy
Lecture 4	Psoriasis Speaker: Angela Considine, PharmD, BCGP, CSP, Supervisor, Specialty Pharmacy, Swedish American Hospital
Lecture 5	Sjögren’s Syndrome Speaker: Sara McCoy, MD, Assistant Professor, Division of Pheumatology, UW Health Sjögren’s Syndrome Clinic
Lecture 6	Rheumatoid Arthritis Speaker: Christie Bartels, MD, MS, Assistant Professor, Division of Rheumatology, School of Medicine and Public Health, UW-Madison
Lecture 7	Role of Complementary Medicine in Treating Autoimmune Disease Speakers: Aaron Henkel, ND, Family Clinic of Natural Medicine and Rebecca Georgia, ND, Family Clinic of Natural Medicine
Lecture 8	Systemic Lupus Erythematosus Speaker: Shivani Garg, MD, MS, Assistant Professor, Division of Rheumatology, School of Medicine and Public Health, UW-Madison, Lupus Nephritis Clinic, UW Health
Lecture 9	Inflammatory Bowel Disease Speaker: Poonam Beniwal-Patel, MD, Assistant Professor, Division of Gastroenterology & Hepatology, Medical College of Wisconsin and Froedtert Hospital

Instructors

Policy on Disclosure

It is the policy of the University of Wisconsin–Madison Interprofessional Continuing Education Partnership (ICEP) to identify, mitigate and disclose all relevant financial relationships with ineligible companies* held by the speakers/presenters, authors, planners, and other persons who may influence content of this accredited continuing education (CE). In addition, speakers, presenters and authors must disclose any planned discussion of unlabeled/unapproved uses of drugs or devices during their presentation.

For this accredited continuing education activity all relevant financial relationships have been mitigated and detailed disclosures are listed below.

*Ineligible companies are those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on, patients.

Christie Bartels, MD, MS, Assistant Professor, Divison of Rheumatology, School of Medicine and Public Health, UW-Madison, Madison, WI
Financial Relationship Disclosure: Pfizer (Grant)
Discussion of Unlabeled/Unapproved Uses of Drugs/Devices in Presentation: No

Poonam Beniwal-Patel, MD, Assistant Professor, Division of Gastroenterology & Hepatology, Medical College of Wisconsin and Froedtert Hospital, Milwaukee, WI
Financial Relationship Disclosure: Takeda Pharmaceutical (Contractor)
Discussion of Unlabeled/Unapproved Uses of Drugs/Devices in Presentation: No

Angela Considine, PharmD, BCGP, CSP, Supervisor, Specialty Pharmacy, Swedish American Hospital, Rockford, IL
Financial Relationship Disclosure: No financial relationships with ineligible companies to disclose
Discussion of Unlabeled/Unapproved Uses of Drugs/Devices in Presentation: No

Leslie Dickmann, PhD, MPH, Program Director, Division of Pharmacy Professional Development, UW-Madison School of Pharmacy, Madison, WI
Financial Relationship Disclosure: Genentech (Employment, Stock)
Discussion of Unlabeled/Unapproved Uses of Drugs/Devices in Presentation: No

Shivani Garg, MD, MS, Assistant Professor, Division of Rheumatology, School of Medicine and Public Health, UW-Madison, Lupus Nephritis Clinic, UW Health, Madison, WI
Financial Relationship Disclosure: No financial relationships with ineligible companies to disclose
Discussion of Unlabeled/Unapproved Uses of Drugs/Devices in Presentation: No

Rebecca Georgia, ND, Family Clinic of Natural Medicine, Madison, WI
Financial Relationship Disclosure: No financial relationships with ineligible companies to disclose
Discussion of Unlabeled/Unapproved Uses of Drugs/Devices in Presentation: No

Mary S. Hayney, PharmD, MPH, FCCP, BCPS, Professor (CHS), Pharmacy Practice Division, UW-Madison School of Pharmacy, Madison, WI
Financial Relationship Disclosure: Takeda Medical Research Foundation (Grant), Sanofi Pasteur (Grant)
Discussion of Unlabeled/Unapproved Uses of Drugs/Devices in Presentation: No

Aaron Henkel, ND, Family Clinic of Natural Medicine, Madison, WI
Financial Relationship Disclosure: No financial relationships with ineligible companies to disclose
Discussion of Unlabeled/Unapproved Uses of Drugs/Devices in Presentation: Yes

Sara McCoy, MD, Assistant Professor, Division of Pheumatology, UW Health Sjögren’s Syndrome Clinic, Madison, WI
Financial Relationship Disclosure: Bristol-Myers Squibb (Contractor)
Discussion of Unlabeled/Unapproved Uses of Drugs/Devices in Presentation: No

Natalie Schmitz, PharmD, PhD, Assistant Professor, Pharmacy Practice Division, UW-Madison, School of Pharmacy, Madison, WI
Financial Relationship Disclosure: No financial relationships with ineligible companies to disclose
Discussion of Unlabeled/Unapproved Uses of Drugs/Devices in Presentation: Yes

Planning Committee

Leslie Dickmann, PhD, MPH, Program Director, Division of Pharmacy Professional Development, UW-Madison School of Pharmacy, Madison, WI
Financial Relationship Disclosure: See above

Mary Hayney, RPh, PharmD, MPH, BCPS, Professor (CHS), Pharmacy Practice Division, UW-Madison School of Pharmacy, Madison, WI
Development, UW-Madison School of Pharmacy, Madison, WI
Financial Relationship Disclosure: See above

Chandra Norder-Brandli, DNP, AG-ACNP, FNP, APNP, Clinical Assistant Professor, Adult Gero Acute Care Pop Lead, UW-Madison, School of Nursing, Madison, WI
Financial Relationship Disclosure: No financial relationships with ineligible companies to disclose

Natalie Schmitz, PhD, PharmD, Assistant Professor (CHS), Pharmacy Practice Division, UW-Madison School of Pharmacy, Madison, WI
Development, UW-Madison School of Pharmacy, Madison, WI
Financial Relationship Disclosure: See above

CE Credit

ICEP Logo Accreditation Statement

In support of improving patient care, the University of Wisconsin–Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation Statements

Accreditation Council for Pharmacy Education (ACPE)

The University of Wisconsin–Madison ICEP designates this enduring knowledge based activity for 7.0 hours or 0.7 CEUs of CPE credit. Credit can be earned by successfully completing the activity, the assessment and the evaluation. There will be no partial credit awarded for partial completion.
JA0000358-0000-21-086-H01-P

Continuing Education Units (CEUs)

The University of Wisconsin–Madison ICEP, as a member of the University Professional & Continuing Education Association (UPCEA), authorizes this program for 0.70 CEUs or 7.0 hours.

Program Coordinator

Leslie Dickmann, PhD, MPH

Division of Pharmacy Professional Development
777 Highland Avenue
Madison, WI 53705
(608) 262-2431 FAX
(608) 265-8249
ljdickmann@wisc.edu

Let’s Stay Connected!

Stay connected with DPPD to receive general programming announcements and related information about our continuing education and professional development programming!
Name*
First Last
Email*
Phone
Postal Code
Profession*
Program(s) of Interest
Program(s) of Interest
Program(s) of Interest